CRUX builds smart insoles that monitor pressure, temperature, and gait in real time to help clinics detect foot complications early.
Diabetic foot ulcers affect millions worldwide, yet most complications go unnoticed until it's too late.
Will develop a foot ulcer in their lifetime — and 25-30% of all diabetic patients face this risk, with many cases going undetected until it's too late.
Average cost to treat a diabetic foot ulcer, escalating rapidly with delayed detection.
Patients with nerve damage can't feel injuries developing, missing critical early warning signs.
Built for doctors. Designed for patients. Currently in prototype development with medical-grade sensors.
Medical-grade sensors detect abnormal pressure distribution across the foot, identifying high-risk zones before tissue damage occurs.
Continuous thermal tracking spots inflammation and infection early—key indicators of developing ulcers.
Motion sensors analyze walking patterns to detect gait abnormalities that may increase ulcer risk.
Wireless connectivity delivers real-time data to the clinical dashboard for immediate insights and automated alerts.
From patient comfort to clinical action—seamless preventive care in four steps.
Comfortable, discreet insoles fit into regular footwear. Patients go about their daily activities normally.
Continuous tracking of pressure, temperature, and gait patterns throughout the day—24/7 protection.
Secure cloud sync delivers real-time insights to your clinic's dashboard with patient history and trends.
Automated warnings notify clinicians of concerning patterns, enabling preventive intervention before ulcers form.
Partner with CRUX to bring proactive diabetic foot monitoring to your patients through our flexible subscription service.
Early detection can prevent expensive ulcer treatments, surgeries, and hospital readmissions.
Proactive monitoring demonstrates commitment to preventive care, improving follow-up rates and loyalty.
Cost-effective B2B pricing designed for clinics and hospitals. Scale as your practice grows.
Access comprehensive analytics and longitudinal patient data to inform treatment decisions.
"The technology CRUX is developing addresses a critical gap in diabetic care. As medical advisors, we believe this preventive approach can truly make a difference for patients living with neuropathy."
CRUX started with a story close to home.
One of our teachers, a diabetic patient, shared that her right foot had gone completely numb due to neuropathy. She explained how she often has to walk long distances but lives with a constant fear — "What if I get a foot ulcer and don't even realize it?"
That moment stayed with us. It wasn't just about her — it represented millions of diabetic patients who silently live with the same anxiety every day. Despite medical advances, there was no simple, preventive solution to help them stay safe in their daily lives.
That conversation sparked CRUX. Founded in March 2025, we decided to build a smart insole that could sense what the patient can't feel — continuously monitoring pressure, temperature, and motion to detect early signs of risk.
With medical advisors guiding our development, we're building technology that gives every diabetic patient the confidence to walk without fear.
Give every diabetic patient the confidence to walk without fear
Built with medical advisors who believe in preventive care
Designed to sense what patients can't feel due to neuropathy
Interested in our B2B subscription model for your clinic or hospital? We're currently in prototype development and looking for forward-thinking healthcare partners. Let's explore how CRUX can help your patients walk with confidence.